Skip to main content

Advertisement

SpringerLink
Log in

The Effect of Providing Information about Lymphedema on the Cognitive and Symptom Outcomes of Breast Cancer Survivors

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Despite recent advances in breast cancer treatment, breast cancer related lymphedema (BCRL) continues to be a significant problem for many survivors. Some BCRL risk factors may be largely unavoidable, such as mastectomy, axillary lymph node dissection (ALND), or radiation therapy. Potentially avoidable risk factors unrelated to breast cancer treatment include minor upper extremity infections, injury or trauma to the arm, overuse of the limb, and air travel. This study investigates how providing information about BCRL affects the cognitive and symptomatic outcome of breast cancer survivors.

Methods

Data were collected from 136 breast cancer survivors using a Demographic and Medical Information interview instrument, a Lymphedema Education Status interview instrument, a Knowledge Test for cognitive outcome, and the Lymphedema and Breast Cancer Questionnaire for symptom outcome. Data analysis included descriptive statistics, t tests, chi-square (χ2) tests, and regression.

Results

BCRL information was given to 57% of subjects during treatment. The mean number of lymphedema-related symptoms was 3 symptoms. Patients who received information reported significantly fewer symptoms and scored significantly higher in the knowledge test. After controlling for confounding factors, patient education remains an additional predictor of BCRL outcome. Significantly fewer women who received information about BCRL reported swelling, heaviness, impaired shoulder mobility, seroma formation, and breast swelling.

Conclusions

Breast cancer survivors who received information about BCRL had significantly reduced symptoms and increased knowledge about BCRL. In clinical practice, breast cancer survivors should be engaged in supportive dialogues so they can be educated about ways to reduce their risk of developing BCRL.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, et al. SEER Cancer Statistics Review, 1975–2006. National Cancer Institute; 2009; http://seer.cancer.gov/csr/1975_2006/.

  2. Norman SA, Localio AR, Potashnik SL, Simoes Torpey HA, Kallan MJ, et al. Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol. 2009;27:390–7.

    Article  PubMed  Google Scholar 

  3. Clark B, Sitzia J, Harlow W. Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study. QJM. 2005;98:343–8.

    Article  CAS  PubMed  Google Scholar 

  4. Engel J, Kerr J, Schlesinger-Raab A, Sauer H, Holzel D. Axilla surgery severely affects quality of life: results of a 5-year prospective study in breast cancer patients. Breast Cancer Res Treat. 2003;79:47–57.

    Article  PubMed  Google Scholar 

  5. Herd-Smith A, Russo A, Muraca MG, Del Turco MR, Cardona G. Prognostic factors for lymphedema after primary treatment of breast carcinoma. Cancer. 2001;92:1783–7.

    Article  CAS  PubMed  Google Scholar 

  6. Paskett ED, Naughton MJ, McCoy TP, Case LD, Abbott JM. The epidemiology of arm and hand swelling in premenopausal breast cancer survivors. Cancer Epidemiol Biomarkers Prev. 2007;16:775–82.

    Article  PubMed  Google Scholar 

  7. Petrek JA, Senie RT, Peters M, Rosen PP. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer. 2001;92:1368–77.

    Article  CAS  PubMed  Google Scholar 

  8. Ahmed RL, Prizment A, Lazovich D, Schmitz KH, Folsom AR. Lymphedema and quality of life in breast cancer survivors: the Iowa Women’s Health Study. J Clin Oncol. 2008;26:5689–96.

    Article  PubMed  Google Scholar 

  9. Tsai RJ, Dennis LK, Lynch CF, Snetselaar LG, Zamba GK, Scott-Conner C. The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol. 2009;16:1959–72.

    Article  PubMed  Google Scholar 

  10. Deutsch M, Land S, Begovic M, Sharif S. The incidence of arm edema in women with breast cancer randomized on the National Surgical Adjuvant Breast and Bowel Project study B-04 to radical mastectomy versus total mastectomy and radiotherapy versus total mastectomy alone. Int J Radiat Oncol Biol Phys. 2008;70:1020–4.

    PubMed  Google Scholar 

  11. Casley-Smith JR. Lymphedema initiated by aircraft flights. Aviat Space Environ Med. 1996;67:52–6.

    CAS  PubMed  Google Scholar 

  12. De Godoy JM, da Silva SH. Prevalence of cellulitis and erysipelas in post-mastectomy patients after breast cancer. Arch Med Sci. 2007;3:249–51.

    Google Scholar 

  13. Schmitz K, Ahmed R, Troxel A, Cheville A, Smith R, Lewis-Grant L, et al. Weight lifting in women with breast-cancer-related lymphedema. New Engl J Med. 2009;361:664–73.

    Article  CAS  PubMed  Google Scholar 

  14. Ahmed R, Thomas W, Yee D, Schmitz K. Randomized controlled trial of weight training and lymphedema in breast cancer survivors. J Clin Oncol. 2006;24:2765–72.

    Article  PubMed  Google Scholar 

  15. Harris SR, Niesen-Vertommen SL. Challenging the myth of exercise-induced lymphedema following breast cancer: a series of case reports. J Surg Oncol. 2000;74:95–8; discussion 98.

    Google Scholar 

  16. McKenzie D, Kalda A. Effect of upper extremity exercise on secondary lymphedema in breast cancer patients: a pilot study. J Clin Oncol. 2003;21:463–6.

    Article  PubMed  Google Scholar 

  17. Armer JM, Radina ME, Porock D, Culbertson SD. Predicting breast cancer-related lymphedema using self-reported symptoms. Nurs Res. 2003;52:370–9.

    Article  PubMed  Google Scholar 

  18. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349:546–53.

    Article  PubMed  Google Scholar 

  19. Purushotham AD, Upponi S, Klevesath MB, Bobrow L, Millar K, Myles JP, et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol. 2005;23:4312–21.

    Article  PubMed  Google Scholar 

  20. Leidenius M, Leivonen M, Vironen J, von Smitten K. The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance. J Surg Oncol. 2005;92:23–31.

    Article  CAS  PubMed  Google Scholar 

  21. Langer I, Guller U, Berclaz G, Koechli OR, Schaer G, Fehr MK, et al. Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg. 2007;245:452–61.

    Article  PubMed  Google Scholar 

  22. Golshan M, Martin WJ, Dowlatshahi K. Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection. Am Surg. 2003;69:209–11; discussion 212.

    PubMed  Google Scholar 

  23. Rietman JS, Dijkstra PU, Geertzen JH, Baas P, de Vries J, Dolsma WV, et al. Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer. Ann Surg Oncol. 2004;11:1018–24.

    Article  CAS  PubMed  Google Scholar 

  24. Ronka R, von Smitten K, Tasmuth T, Leidenius M. One-year morbidity after sentinel node biopsy and breast surgery. Breast. 2005;14:28–36.

    Article  CAS  PubMed  Google Scholar 

  25. Wilke LG, McCall LM, Posther KE, Whitworth PW, Reintgen DS, Leitch AM, et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol. 2006;13:491–500.

    Article  PubMed  Google Scholar 

  26. Sener SF, Winchester DJ, Martz CH, Feldman JL, Cavanaugh JA, Winchester DP, et al. Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer. 2001;92:748–52.

    Article  CAS  PubMed  Google Scholar 

  27. Schunemann H, Willich N. Lymphoedema of the arm after primary treatment of breast cancer. Anticancer Res. 1998;18:2235–6.

    CAS  PubMed  Google Scholar 

  28. van der Veen P, De Voogdt N, Lievens P, Duquet W, Lamote J, Sacre R. Lymphedema development following breast cancer surgery with full axillary resection. Lymphology. 2004;37:206–8.

    PubMed  Google Scholar 

  29. Armer J, Fu MR, Wainstock JM, Zagar E, Jacobs LK. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy. Lymphology. 2004;37:73–91.

    CAS  PubMed  Google Scholar 

  30. Nesvold IL, Dahl AA, Lokkevik E, Marit Mengshoel A, Fossa SD. Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy. Acta Oncol. 2008;47:835–42.

    Article  PubMed  Google Scholar 

  31. Yen TW, Fan X, Sparapani R, Laud PW, Walker AP, Nattinger AB. A contemporary, population-based study of lymphedema risk factors in older women with breast cancer. Ann Surg Oncol. 2009;16:979–88.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

This study was supported by a research grant from Avon Foundation, a grant from the Hartford Institute for Geriatric Nursing, and NYU Pless Center of Nursing Research.

Author information

Authors and Affiliations

  1. College of Nursing, New York University, New York, NY, USA

    Mei R. Fu PhD, RN, ACNS-BC & Judith Haber PhD, RN, APRN-BC, FAAN

  2. Division of Plastic and Reconstructive Surgery, New York Eye and Ear Infirmary, New York, NY, USA

    Constance M. Chen MD, MPH

  3. Department of Surgery, New York University Clinical Cancer Center, New York University School of Medicine, New York, NY, USA

    Amber A. Guth MD, FACS & Deborah Axelrod MD, FACS

Authors
  1. Mei R. Fu PhD, RN, ACNS-BC
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Constance M. Chen MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Judith Haber PhD, RN, APRN-BC, FAAN
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Amber A. Guth MD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Deborah Axelrod MD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mei R. Fu PhD, RN, ACNS-BC.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fu, M.R., Chen, C.M., Haber, J. et al. The Effect of Providing Information about Lymphedema on the Cognitive and Symptom Outcomes of Breast Cancer Survivors. Ann Surg Oncol 17, 1847–1853 (2010). https://doi.org/10.1245/s10434-010-0941-3

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-010-0941-3

Keywords

Search

Navigation